Learn / VCYT
NASDAQ: VCYTVeracyte (VCYT) stock, explained like you're 5
Veracyte trades on the Nasdaq under the ticker VCYT. It is a mid cap company in the medical specialities industry, part of the healthcare sector, with a market value of about 3.6 billion dollars.
- Ticker
- VCYT
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Medical Specialities
- Size
- Mid cap, about 3.6 billion dollars
Is Veracyte a small, medium or large cap company?
No. Veracyte is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 3.6 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Veracyte makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves VCYT stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Does Veracyte (VCYT) Trade At A Discount To Future Cash Flow? (Simply Wall Street)
- Veracyte secures Medicare coverage: 11 analysts rate Veracyte stock (ad-hoc-news.de)
- Is it Worth Adding Veracyte Stock to Your Portfolio Now? (Yahoo Finance)
- A breast cancer test could spare chemotherapy for more than two thirds of clinically high risk patients (Stock Titan)
- Veracyte (NASDAQ:VCYT): Affordable Growth Backed by Strong Fundamentals (ChartMill)
Follow VCYT in your daily brief
Each trading day at 5 PM ET we post what happened to Veracyte and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow VCYT
Questions about Veracyte stock
What does Veracyte do?
Veracyte trades on the Nasdaq under the ticker VCYT. It is a mid cap company in the medical specialities industry, part of the healthcare sector, with a market value of about 3.6 billion dollars.
What is the ticker symbol for Veracyte?
Veracyte trades under the ticker VCYT on the Nasdaq.
What is Veracyte's market cap?
Veracyte is a mid cap stock with a market cap of about 3.6 billion dollars.
How does Veracyte make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves VCYT stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow VCYT stock every day?
Add VCYT to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.
